The global postpartum depression market size reached USD 5.10 Billion in 2021 and is expected to register a revenue CAGR of 30.4% during the forecast period. Rising demand for easily accessible treatment methods of postpartum depression is a crucial factor driving market revenue growth.
Postpartum Depression (PPD) is a medical condition which is observed in individuals who have given childbirth recently. According to the Centers for Disease Control and Prevention (CDC), around one in eight women suffer from PPD in the U.S. Hormonal imbalance, changes in home and work environment, and lack of sleep among other factors have been attributed as possible reasons for occurrence of the medical condition during postpartum period of the mother. Treatment is usually done using drugs, antidepressants, hormonal therapies, as well as cognitive behavior therapies.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1079
Recent advances in drug discovery and development have resulted in emergence of therapeutic alternatives for treatment of PPD. Novel drugs and synthetic neurosteroids have received approval from the Food and Drug Administration in recent years, which is accelerating treatment of postpartum depression and is projected to support revenue growth of the market between 2022 and 2030.
In the latest report from Emergen Research, the market research report discusses the global Postpartum Depression market in depth, and each of the major market segments is examined in depth. In addition to market information, the report provides industry statistics, regional market revenue shares, gross profits, production & distribution costs, and product portfolios related to the global Postpartum Depression market. There are also a number of factors influencing industry revenue growth identified in the report, including drivers, opportunities, trends, restraints, challenges, demand and supply ratios, production and consumption patterns, stringent regulatory frameworks, as well as a multitude of other micro- and macro-economic factors.
Competitive Terrain:
The Global Postpartum Depression Market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graph, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market at length. The report scrutinizes the strategic approach of key market players towards expanding their product offerings and fortifying their market foothold.
Key players in the market include Pfizer Inc., Sage Therapeutics, Lipocine Inc., Eli Lilly and Company, GlaxoSmithKline, Inc., Postpartum Support International, The Motherhood Center of New York, Talkspace, Included Health Inc., She Matters, and Canopie.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1079
Some Key Highlights From the Report
Hormonal therapy segment is expected to register steady revenue CAGR during the forecast period. Increasing number of emerging number of therapeutic alternatives for treatment of postpartum depression through administration of hormones is projected to drive revenue growth of this segment between 2022 and 2030. A research study published in August 2021 reported the use of neurosteroid replacement therapy for treatment of PPD in patients within the first four weeks of childbirth. In 2019, the U.S. Food and Drug Administration approved use of a brexanolone, which is a synthetic version of the allopregnanolone steroid for treatment of PPD.
Hospitals segment accounted for a significantly robust revenue share in 2021. Increasing number of birth in hospitals and availability of healthcare providers and doctors on hospital premises are key factors driving revenue growth of this segment. Over 98% births happen in hospitals in the United States each year. Doctors treating mothers of newborns are able to correctly diagnose symptoms of postpartum depression in case the patient displays them in the duration of the hospital stay, and provide them with medicinal and cognitive therapies to cure the medical condition.
Market in Asia Pacific accounted for largest revenue share in the global postpartum depression market in 2021. Increasing population, implying increasing number of childbirths and rapid innovations in telemedicine as well as increasing research initiatives related to treatment of PPD are major factors driving revenue growth of the postpartum depression market in the Asia Pacific. A research study published in June 2021 reported the identification of potential biomarkers that can be used for early detection of PPD in patients.
Additionally, the report covers the analysis of the key players in the industry with a special focus on their global position, financial status, and their recent developments. Porter’s Five Forces Analysis and SWOT analysis have been covered by the report to provide relevant data on the competitive landscape.
Detailed Regional Analysis covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Emergen Research has segmented global postpartum depression market on the basis of symptoms, treatment type, treatment centers, and region:
Symptoms Outlook (Revenue, USD Billion; 2019-2030)
Hormonal Changes and Imbalance
Anxiety
Severe Fatigue
Mood Swings
Others
Treatment Type Outlook (Revenue, USD Billion; 2019-2030)
Drugs
Cognitive Behavioral Therapy
Anti-Psychotics
Antidepressants
Hormonal Therapy
Others
Treatment Centers Outlook (Revenue, USD Billion; 2019-2030)
Hospitals
Helplines
Mental Health Communities
Mental Health Clinics
Home Care
Others
To know more about the report @ https://www.emergenresearch.com/industry-report/postpartum-depression-market
Key reasons to buy the Global Postpartum Depression Market report:
The latest report comprehensively studies the global Postpartum Depression market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
The report offers an insightful analysis of the regional outlook of the market.
It offers a detailed account of the end-use applications of the products & services offered by this industry.
The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/1079
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
Take a Look at our other Reports:
Point of Care Testing Market
Sports Medicine Market
Telehealth Market
Continuous Glucose Monitoring System Market
Hearing Aids Market
Mammography System Market
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-postpartum-depression-market